Oncology Information Systems Market: Cloud-Based Platforms, Data Security Enhancements & Industry Forecast to 2033

Integrating healthcare IT solutions with clinical workflows is revolutionizing the way cancer care is delivered globally. By automating data handling and treatment planning, these systems reduce manual errors and allow clinicians to focus on personalized patient outcomes. According to IMARC Group’s latest data, the global oncology information systems market size was valued at USD 4.2 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 7.3 Billion by 2033, exhibiting a CAGR of 5.95% from 2025-2033.

Oncology information systems (OIS) have evolved into a critical multi-billion-dollar infrastructure, essential for managing the complex, multi-modal nature of modern cancer treatments. Growth is fueled by the rising global cancer burden and a strategic shift toward data-driven oncology, where real-time information sharing across multidisciplinary teams is paramount. Hospitals and diagnostic centers are increasingly investing in software solutions to integrate medical, radiation, and surgical oncology data into a unified patient record. Key segments include patient information systems, treatment planning software, and professional services, with a strong emphasis on interoperability, cybersecurity, and the integration of artificial intelligence to optimize clinical pathways.

Oncology Information Systems Market Growth Drivers:

• Rising Global Cancer Burden and Patient Volume

The increasing prevalence of various cancer types globally is the primary engine driving the adoption of specialized information systems. As patient volumes grow, healthcare facilities face immense pressure to manage complex treatment schedules and vast amounts of diagnostic data. Modern OIS solutions provide the necessary scalability to handle this influx, ensuring that patient records, from initial biopsy to long-term follow-up, remain accessible and organized. This high demand is particularly evident in urban healthcare hubs where throughput is high, necessitating automated systems to prevent administrative bottlenecks and maintain high standards of patient safety.

• Shift Toward Precision Medicine and Targeted Therapies

The move from a "one-size-fits-all" approach to personalized oncology requires sophisticated data management that traditional electronic health records often lack. Oncology-specific systems are designed to integrate genomic data, molecular profiling, and advanced imaging to help clinicians tailor therapies to individual genetic markers. This precision-focused environment relies on OIS to track specific drug responses and manage the complexities of immunotherapy and targeted clinical trials. By providing a granular view of patient data, these systems empower oncology teams to make evidence-based decisions that improve survival rates and reduce the side effects of conventional treatments.

Download Free “Oncology Information Systems Market” Report Preview

• Digital Transformation and Government Support for E-Health

Governments worldwide are incentivizing the digitization of healthcare records to improve national health outcomes and reduce long-term costs. Initiatives like the "Cancer Moonshot" in the United States and various "E-Health" programs across Europe and Asia provide the regulatory and financial framework for hospitals to upgrade their legacy systems. These policies often mandate the use of certified health IT to ensure data security and interoperability. By aligning with these national digital health goals, oncology departments can access funding and support for implementing high-end information systems that streamline workflows and facilitate large-scale clinical research and reporting.

Oncology Information Systems Market Trends:

• Integration of Artificial Intelligence and Predictive Analytics

A major shift is occurring as OIS providers embed AI-driven tools directly into their platforms to assist in treatment planning and dose optimization. These intelligent systems analyze historical patient data to predict potential treatment outcomes or identify patients at high risk for complications. For instance, AI algorithms can now assist radiation oncologists by automatically contouring organs at risk, significantly reducing the time required for planning. This trend toward "intelligent" oncology not only enhances the accuracy of radiotherapy and chemotherapy but also helps in optimizing resource allocation within busy cancer centers, making care both faster and more precise.

• Expansion of Cloud-Based and Interoperable Platforms

The industry is moving away from siloed, on-premise servers toward cloud-native oncology systems that allow for seamless data exchange between different healthcare providers. Cloud deployment enables real-time collaboration between surgeons, radiologists, and medical oncologists, regardless of their physical location. This is particularly vital for tumor board reviews and second opinions. Enhanced interoperability standards, such as FHIR (Fast Healthcare Interoperability Resources), are being adopted to ensure that OIS can "talk" to other hospital systems. This connectivity reduces data duplication, minimizes the risk of lost information, and ensures a continuous "golden thread" of patient data throughout the care continuum.

• Emphasis on Patient-Centric Portals and Navigation

There is a growing trend to include patient-facing components within oncology information systems to improve engagement and navigation. These portals allow patients to view their treatment summaries, track symptoms in real-time through PROMs (Patient-Reported Outcome Measures), and communicate directly with their care teams. By involving patients in their own data journey, providers can improve treatment adherence and catch potential complications earlier. Market leaders are increasingly focusing on these "human-centric" features, recognizing that a well-informed patient is a core component of a successful oncology program, leading to better psychological outcomes and overall satisfaction during the treatment process.

Recent News and Developments in Oncology Information Systems Market

• February 2025: Elekta AB launched its latest cloud-based oncology information system, designed to enable seamless integration across hospital networks and provide clinicians with enhanced mobile access to real-time patient data and treatment plans.
• September 2024: GE Healthcare announced a strategic partnership with several leading U.S. health systems to pilot a blockchain-integrated oncology platform aimed at securing sensitive patient data while facilitating easier sharing for multidisciplinary tumor boards.
• May 2024: RaySearch Laboratories AB released RayCare 2024A, its next-generation OIS, which features improved interoperability with Varian TrueBeam linear accelerators, allowing for more streamlined workflows in radiation therapy departments.
• January 2024: The White House reaffirmed its commitment to the Cancer Moonshot initiative, specifically highlighting the role of digital health technology and patient navigation systems in reducing the burden of cancer care for families and improving clinical trial access.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.